Gilead Sciences EVP Keeley M. Cain Wettan Reports Routine RSU Vesting and Tax Withholding

Executive Summary

On September 11, 2026, Gilead Sciences, Inc. ($GILD) filed a Form 4 reporting transactions by Keeley M. Cain Wettan, EVP General Counsel, Legal & Compliance. The filing reflects the vesting of 590 Restricted Stock Units (RSUs) on September 10, 2026, and the subsequent automatic withholding of 285 shares of common stock at $144.81 per share ($41,270.85 total value) to satisfy tax withholding obligations.

Transaction Breakdown

• RSU Conversion (Code M): 590 RSUs were converted into 590 shares of common stock at no cost upon vesting.
• Tax Withholding (Code F): 285 shares were withheld by the company at $144.81 per share to cover statutory tax liabilities associated with the vesting event.
• Net Share Increase: +305 common shares directly owned.
• Post-Transaction Direct Holdings: 8,759 common shares and 13,405 unvested RSUs.

Market & Trading Significance

This filing represents a routine, non-discretionary administrative event related to equity compensation vesting schedules. It does not indicate open-market buying or selling activity and carries Low trading significance for investors.